ASX-listed medicinal cannabis group Creso Pharma (ASX:CPH) raised $18 million in a share placement this week. Capital markets Corporate Advisory Firm EverBlu Capital led the deal. And investors...
ASX:CPH
Agreement to acquire established Canadian psychedelics company Halucenex Life Sciences Inc.
Highlights Halucenex is a Psychedelic-Assisted Psychotherapy (PAP) company Halucenex focuses on the commercialisation and R&D of novel psychedelic molecules for the treatment of Post Traumatic...
LOI Secured With ImpACTIVE To Drive Growth In North America And Europe
▪ ImpACTIVE is a Canadian company focused on CBD-based products that reduce muscle and joint inflammation ▪ Creso has entered into a non-binding LOI for the distribution of...
This Company Has Developed a Range of Market-Leading Complementary Feed Products Specifically Formulated For Pets…
CRESO PHARMA (ASX:CPH) Creso Pharma – The Rapidly Growing Firm at the Vanguard of the New Green Pet Product Market The demand for cannabidiol products is growing. And it’s growing fast. The industry...
Creso’s wholly owned Canadian subsidiary Mernova Medicinal Inc. secures four new purchase orders (POs) totalling C$494,131 (A$502,1991)
Highlights Purchase orders (POs) received for Ritual Green products highlight significant demand$343,331 ($348,7261) in POs from the Ontario Cannabis Store mark Mernova’s entry into Canada’s largest...
Distribution Agreement Secured for Innovative Hemp Derived Therapeutic Products in Pakistan, Philippines and Other New Markets
Up to CHF1.71m (AUD2.48m1) minimum order quantity across CannaQix 10, Cannaqix 50 and CannaDOL product lines. Highlights: Creso enters into Distribution Agreement with Route2 Pharm Pvt Ltd in...
This Company Is Maximizing its Growth in an Emerging Sector With a Three-Pillar Strategy
CRESO PHARMA (ASX:CPH) Creso Pharma – a Unique Stock Already Attracting the Biggest Names in the Green Business. When you first look at what Creso Pharma...
Creso Pharma welcomes OTC sale of CBD products in Australia
Highlights: Low-dose CBD products can now be sold over-the-counter in Australian pharmacies as of today (1 Feb 2021) Follows TGA’s decision to down schedule low-dose CBD products from...
Mernova Medicinal Inc. secures licensing and supply agreement with Khalifa Kush Enterprises
Value – up to AUD$10.25m HighlightsKhalifa Kush Enterprises (KKE) is the Canadian arm of Wiz Khalifa’s global cannabis companyDeal is worth up to $10.25m for CresoMernova and KKE will collaborate to...